0.5921
14-February-25 16:45:00
15 minutes delayed
Stocks
+0.0321
+5.73%
Today's range
0.5503 - 0.5959
ISIN
N/A
Source
NASDAQ
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
25 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
28 May 2024 07:03:00 By Nasdaq GlobeNewswire